Mount Sinai Icahn School of Medicine — New York, New York

Mount Sinai Icahn School of Medicine is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai Icahn School of Medicine has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation.

Sponsors: AtriCure, Inc., The Medicines Company, Johns Hopkins University.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Icahn School of Medicine?

Mount Sinai Icahn School of Medicine has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Icahn School of Medicine conducted?

Mount Sinai Icahn School of Medicine has 3 clinical trials on record, with 1 currently active. Their work covers Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation.

Is Mount Sinai Icahn School of Medicine accredited by Crixeo Health?

Mount Sinai Icahn School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Icahn School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.